PERRIGO Co plcPRGO
時価総額
$17.4億
PER
セルフケア製品の最大手。OTC・プライベートブランド医薬品とOpillのOTC化を展開。2022年4月に約18億ユーロで欧州ブランドを買収、2022年11月に工場を1.1億ドルで取得。米国・欧州・豪州中心に展開。
| 2014年 6月28日 | 2015年 6月27日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Net sales | - | - | - | - | 4,732 | 4,837 | 5,063 | 4,139 | 4,452 | 4,656 | 4,373 |
| Cost of sales | 2,613 | - | 3,229 | 2,967 | 2,900 | 3,064 | 3,248 | 2,723 | 2,996 | 2,975 | 2,831 |
| Gross profit | 1,448 | 1,713 | 2,052 | 1,980 | 1,832 | 1,773 | 1,815 | 1,416 | 1,455 | 1,680 | 1,543 |
| Distribution | - | 68 | 88 | 87 | 94 | 96 | 100 | 93 | 113 | 111 | 98 |
| Research and development | 153 | 188 | 184 | 168 | 219 | 187 | 178 | 122 | 123 | 123 | 112 |
| Selling | 209 | 319 | 665 | 598 | 596 | 567 | 579 | 536 | 585 | 642 | 547 |
| Administration | 411 | 385 | 452 | 461 | 436 | 503 | 496 | 482 | 512 | 522 | 468 |
| Impairment charges | - | - | 2,631 | 48 | 224 | 185 | 347 | 173 | - | 90 | 89 |
| Restructuring | 47 | 5 | 31 | 61 | 21 | 26 | 4 | 17 | 43 | 42 | 110 |
| Other operating (income) expense, net | - | - | - | 41 | - | - | - | - | - | - | -6 |
| Total operating expenses | - | 965 | 4,052 | 1,381 | 1,595 | 1,569 | 1,700 | 1,006 | 1,377 | 1,529 | 1,430 |
| Operating income | 567 | 748 | -2,000 | 598 | 237 | 205 | 115 | 410 | 79 | 152 | 113 |
| Interest expense, net | - | - | - | - | - | - | - | - | - | - | -188 |
| Other (income) expense, net | -12 | - | -23 | 10 | -6 | 66 | -17 | -27 | -53 | 10 | 1 |
| (Gain) loss on extinguishment of debt | -166 | -10 | -1 | -135 | -0 | -0 | -20 | - | -9 | 3 | -7 |
| Income (loss) from continuing operations before income taxes | - | - | - | - | - | - | - | - | - | -8 | -81 |
| Income tax (benefit) expense | 67 | 120 | -835 | 161 | 160 | 25 | 13 | 390 | -8 | -4 | 80 |
| Income (loss) from continuing operations | - | - | - | - | - | - | - | -131 | -131 | -4 | -161 |
| Loss from discontinued operations, net of tax | - | - | - | - | - | - | - | 62 | -10 | -8 | -11 |
| Net income (loss) | 205 | 128 | -4,013 | 120 | 131 | 146 | -163 | -69 | -141 | -13 | -172 |
| Continuing operations (in dollars per share) | 1.78 | - | - | - | - | - | - | -0.98 | -0.97 | -0.03 | -1.17 |
| Discontinued operations (in dollars per share) | - | - | - | - | - | - | - | 0.46 | -0.07 | -0.06 | -0.08 |
| Basic earnings (loss) per share (in dollars per share) | 1.78 | 0.92 | -28.01 | 0.84 | 0.95 | 1.07 | -1.19 | -0.52 | -1.04 | -0.09 | -1.25 |
| Continuing operations (in dollars per share) | 1.77 | - | - | - | - | - | - | -0.98 | -0.97 | -0.03 | -1.17 |
| Discontinued operations (in dollars per share) | - | - | - | - | - | - | - | 0.46 | -0.07 | -0.06 | -0.08 |
| Diluted earnings (loss) per share (in dollars per share) | 1.77 | 0.92 | -28.01 | 0.84 | 0.95 | 1.07 | -1.19 | -0.52 | -1.04 | -0.09 | -1.25 |